Takeda Pharmaceutical (TKPHF) Intangibles (2017 - 2026)

Takeda Pharmaceutical's Intangibles history runs 10 years deep, the most recent figure standing at $21.8 billion for Q1 2026.

• In Q1 2026, Intangibles fell 8.4% year-over-year to $21.8 billion; the TTM figure through Mar 2026 stood at $21.8 billion (down 8.4% YoY), while the FY2026 annual figure was $22.7 billion, down 4.72% from the prior year.
• Intangibles was $21.8 billion for Q1 2026 at Takeda Pharmaceutical, down from $22.8 billion in the prior quarter.
• In the past five years, Intangibles ranged from a high of $32.9 billion in Q2 2023 to a low of $21.8 billion in Q1 2026.
• Historically, Intangibles has averaged $27.5 billion across 5 years, with a median of $27.7 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Intangibles decreased 20.09% in 2022, then advanced 3.98% in 2023.
• A 5-year view of Intangibles shows it stood at $26.7 billion in 2022, then climbed by 3.98% to $27.7 billion in 2023, then slipped by 6.21% to $26.0 billion in 2024, then fell by 12.12% to $22.8 billion in 2025, then slipped by 4.56% to $21.8 billion in 2026.
• The last three Intangibles figures came in at $21.8 billion (Q1 2026), $22.8 billion (Q4 2025), and $22.4 billion (Q3 2025), per Business Quant data.